Smoking as a trigger for inflammatory rheumatic diseases

Current Opinion in Rheumatology

Volumn 19, Issue 1, 2007, Pages 49-54

  Klareskog, Lars ^a   Padyukov, Leonid ^a   Alfredsson, Lars ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Stockholm Centre of Public Health   (Sweden)

Author keywords

Etiology; Genetics; RA; SLE; Smoking

Indexed keywords

DOUBLE STRANDED DNA ANTIBODY; HLA DR ANTIGEN; NICOTINE;

ANTIBODY DETECTION; CIGARETTE SMOKING; HUMAN; INFLAMMATION; MOLECULAR BIOLOGY; PATHOGENESIS; PATIENT COUNSELING; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK REDUCTION; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS;

ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; COLITIS, ULCERATIVE; HUMANS; INFLAMMATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; RHEUMATIC DISEASES; SMOKING;

EID: 33845361515     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32801127c8     Document Type: Review

References (48)

1. Aho K, Heliövaara M. Risk factors for rheumatoid arthritis. Ann Med 2004; 36:242-251.
2. Vessey MP, Villard-Mackintosh L, Yeates D. Oral contraceptives, cigarette smoking and other factors in relation to arthritis. Contraception 1987; 35:457-464.
3. Karlsson EW, Lee IM, Cook NR, et al. A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Reum 1999; 42:910-917.
4. Uhlig T, Hagen KB, Kvien TK. Current tobacco smoking, formal education, and the risk of rheumatoid arthritis. J Rheumatol 1999; 26:47-54.
5. Stolt P, Bengtsson C, Nordmark B, et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003; 62:835-841.
6. Costenbader KH, Feskanich D, Mandl LA, Karlson EW. Smoking intensity, duration and cessation and the risk of rheumatoid arthritis in women. Am J Med 2006; 119:503-511.
7. Ghaussy NO, Sibbitt WL Jr, Qualls CR. Cigarette smoking, alcohol consumption, and the risk of systemic lupus erythematosus: a case-control study. J Rheumatol 2001; 28:2449-2453.
8. Costenbader KH, Kim DJ, Peerzada J, et al. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum 2004; 50:849-857.
9. Freemer MM, King TE Jr, Criswell LA. Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus. Ann Rheum Dis 2006; 65:581-584. This paper demonstrates how smoking is associated not only with an increased risk for SLE, but also associated with occurrence of anti-dsDNS antibodies.
10. Majka DS, Holers VM. Cigarette smoking and the risk of systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 2006; 65:561-563.
11. Gorman JD. Smoking and rheumatoid arthritis: another reason to just say no. Arthrits Rheum 2006; 54:10-13.
12. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-324.
13. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-1277.
14. Johannesson M, Hultqvist M, Holmdahl R. Genetics of autoimmune diseases: a multistep process. Curr Top Microbiol Immunol 2006; 305:259-276.
15. Rantapää-Dahlqvist S, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48:2741-2749.
16. Nielen MM, van Schaardenburg D, Reesink HW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004; 50:380-386.
17. Thomas GAO, Rhodes J, Ingram JR. Mechanisms of disease. Nicotine: a review of its actions in the context of gastrointestinal disease. Nat Clin Pract Gastr Hepat 2005; 2:536-544.
18. Holmdahl R, Lorentzen JC, Lu S, et al. Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis. Immunol Rev 2001; 184:184-202.
19. Czura CJ, Tracey KJ. Autonomic neural regulation of immunity. J Int Med 2005; 257:156-166.
20. Padyukov L, Silva C, Stolt P, et al. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 2004; 50:3085-3092.
21. Schellekens GA, de Jong BA, van den Hoogen FH, et al. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998; 101:273-281.
22. van der Helm-van Mil AH, Verpoort KN, Breedveld FC, et al. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 2005; 7:R949-R958.
23. Rönnelid J, Wick MC, Lampa J, et al. Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis 2005; 64:1744-1749.
24. Kastbom A, Strandberg G, Lindroos A, Skogh T. Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis 2004; 63:1085-1924.
25. Lundberg K, Nijenhuis S, Vossenaar ER, et al. Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res Ther 2005; 7:R458-R467. This paper demonstrates that citrullination of a protein may increase its immunogenicity as well as its potential to induce arthritis.
26. Kuhn K, Kulik L, Tomoora B, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006; 116:961-973. This paper demonstrates both that monoclonal antibodies against citrullinated fibrinogen can enhance development of arthritis in mice, and that citrullination of collagen II may be involved in the development of collagen induced arthritis.
27. Hill JA, Southwood S, Sette A, et al. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 2003; 171:538-541.
28. Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006; 54:38-4633. This paper first describes that HLA-DRB1 SE as well as smoking are risk factors only for the anticitrulline antibody positive subset of RA and not for the anticitrulline antibody negative subset. An etiologic model for RA is proposed, indicating that smoking induces citrullination as well as activation of immunity to citrullinated proteins, that this immunity can trigger arthritis.
29. ••] in an independent study.
30. Pedersen M, Jacobsen S, Klarlund M, et al. Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptide. Arthritis Res Ther 2006; 8:R133.
31. Makrygiannakis D, Af Klint E, Lundberg IE, et al. Citrullination is an inflammation dependent process. Ann Rheum Dis 2006; 65:1219-1222.
32. Löfdahl M, Wahlström J, Sköld CM. Different inflammatory cell pattern and macrophage phenotype in COPD patients, smokers and non smokers. Clin Exp Immunol 2006; 145:428-437.
33. Manfredsdottir VF, Vikingsdottir T, Jonsson T, et al. A. The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis. Rheumatology (Oxford) 2006; 45:734-740. This paper shows that smoking is not only a risk factor for getting RA, but also makes the disease more severe.
34. Kaushik VV, Hutchinson D, Desmond J, et al. Association between bronchiectasis and smoking in patients with rheumatoid arthritis. Ann Rheum Dis 2004; 63:1001-1002.
35. Klareskog L, Forsum U, Scheynius A, et al. Evidence in support of a selfperpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci U S A 1982; 79:3632-3636.
36. Panayi GS, Corrigall VM, Pitzalis C. Pathogenesis of rheumatoid arthritis: the role of T-cells and other beasts. Rheum Dis Clin North Am 2001; 27:317-334.
37. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349:1526-1533.
38. McClain MT, Heinlen LD, Dennis GJ, et al. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 2004; 11:85-89.
39. Timmer A. Environmental influence on inflammatory bowel disease manifestations. Digest Dis 2003; 21:91-104.
40. Ahmed FE. Role of genes, the environment and their interactions in the etiology of inflammatory bowel diseases. Expert Rev Mol Diagn 2006; 6:345-363.
41. Manguso F, Sanges M, Staiano T, et al. Cigarette smoking and appendectomy are risk factors for extraintestinal manifestations in ulcerative colitis. Am J Gastroenterology 2004; 99:327.
42. Tracey KJ. The inflammatory reflex. Nature 2002; 420:853-859.
43. Borovikova LV, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405:458-462.
44. Casciola Rosen LA, Anhalt GJ, Rosen A. DNA-dependent protein kinase Is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 2005; 182:1625-1634.
45. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30:1205-1213.
46. Sestak AL, Nath SK, Harley JB. Genetics of systemic lupus erythematosus: how far have we come? Rheum Dis Clinics North Am 2005; 31:223-244.
47. Sigurdsson S, Nordmark G, Göring HH, et al. Polymorphism in the tyrosine kinase 2 and interferon factor 5 genes are associated with systemic lupus erythematosus. Am J Genet 2005; 76:528-537.
48. Klareskog L, Padyukov L, Ronnelid J, Alfredsson L. Genes, environment and immunity in the development of rheumatoid arthritis. Curr Opin Immunol. 2006 Sep 27; [Epub ahead of print]